ginsenoside M1

Known as: ginsenoside CK, compound K, 20-O-beta-D-glucopyranosyl-20(S)-protopanaxadiol 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2001-2017
05101520012017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Phytogenic compounds with anti-oxidant and anti-inflammatory properties, such as ginsenoside metabolite compound K (CK) or… (More)
Is this relevant?
2012
2012
Compound K (CK) is a final intestinal metabolite of protopanaxadiol-type ginsenosides (PDG) from Panax ginseng. Although anti… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Is this relevant?
2011
2011
Signal transducer and activator of transcription 3 (STAT3) is an oncogenic transcription factor implicated in carcinogenesis… (More)
Is this relevant?
2011
2011
Human leukocyte endothelial adhesion and transmigration occur in the early stage of the pathogenesis of atherosclerosis. Vascular… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2010
2010
The glucoregulatory activities of ginsenosides compound K (CK) and Rg1 were investigated in 3T3-L1 adipocytes. Both compounds… (More)
Is this relevant?
2009
2009
Compound K (CK) is a major intestinal metabolite of ginsenosides derived from ginseng radix. Although antidiabetic and… (More)
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2009
2009
Although compound K (CK), an intestinal metabolite of ginseng protopanaxadiol saponins, has been known to induce apoptosis in… (More)
Is this relevant?
2007
2007
Compound K (CK) is a final metabolite of panaxadiol ginsenosides. Although Panax ginseng is known to have antidiabetic activity… (More)
Is this relevant?
2007
2007
Compound K (CK) is a major intestinal metabolite of ginsenosides derived from ginseng radix. In our preliminary studies, CK has… (More)
Is this relevant?
2006
2006
In previous reports we demonstrated that ginsenosides, active ingredients of Panax ginseng, affect some subsets of voltage… (More)
Is this relevant?